Recall two batches of cinac 30 mg
2026-02-12
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer cinac 30 mg tablet CINACALCET 2305233694 23D590 & 23D589 Abdi Ibrahim Ilac San ve Tic A.S.
التصنيف
ملف
التاريخ
2025-08-24
اسم المستحضر
Cinac 30 mg
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
The SFDA has issued a recall for two batches of Cinac tablets due to out-of-specification levels of the N-Nitroso Cinacalcet impurity.
التوصيات
For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.